A Study of the Efficacy and Tolerability of Once Daily Celecoxib and Twice Daily Naproxen vs. Placebo in the Treatment of Subjects With Osteoarthritis of the Knee

Trial Profile

A Study of the Efficacy and Tolerability of Once Daily Celecoxib and Twice Daily Naproxen vs. Placebo in the Treatment of Subjects With Osteoarthritis of the Knee

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Dec 2017

At a glance

  • Drugs Celecoxib (Primary) ; Naproxen
  • Indications Osteoarthritis
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 11 Dec 2017 New trial record
    • 01 Dec 2017 Results (n=441) of analysis comparing safety and efficacy of celecoxib with placebo in Asian and Non Asian population using patient data from A3191052 and A3191063 trials published in the Pain and Therapy
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top